Search - tctmd.com

Displaying 101 - 120 of 436

Sort: Relevancy | Date

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

Hypertension Care Pathway with uRDN: Experiences from Clinical Trials

Presenter: NULL

October 25, 2023

Presentation TCT 2023

A High Standard of Clinical Evidence: Recent Key Milestones

Presenter: NULL

October 25, 2023

Presentation TCT 2023

TCT 628: The Impact of Long-term Exposure to Air Pollution on Plaque Characteristics Assessed by Intravascular Optical Coherence Tomography

Presenter: Juhwan Lee

October 25, 2023

Presentation TCT 2023

TCT 555: NIRS-Detected Lipid-Rich Plaques are Highly Responsive to Novel Escalated LDL-C Reduction Therapy

Presenter: Karlis Trusinskis

October 25, 2023

Presentation TCT 2023

TCT 379: Impact of the Residual Lipid Burden on the Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention

Presenter: Woohyeun Kim

October 25, 2023

Presentation TCT 2023

TCT 252: NIRS-IVUS assessment of OCT-derived Healed Coronary Plaques

Presenter: Kosei Terada

October 25, 2023

Presentation TCT 2023

TCT 235: Patterns of High-Risk Endothelial Shear Stress and Endothelial Shear Stress Gradients in Plaques with Abnormal vs Normal Resting Fractional Flow Reserve Ratio

Presenter: Diaa Hakim

October 25, 2023

Presentation TCT 2023

TCT 161: Coronary Lipid Burden Early After Heart Transplantation as Assessed by Optical Coherence Tomography (OCT)

Presenter: Daneyal Syed

October 25, 2023

Presentation TCT 2023

TCT 116: Clinical Outcomes of AMI Arising from Non-lipid-rich Plaque determined by NIRS-IVUS

Presenter: Kosei Terada

October 25, 2023

Presentation TCT 2023

TCT 645: Changes in Plaque Lipid Content After 1 year Intensive Versus Standard Statin Therapy : CITRUS study (Serial near-infrared spectroscopy assessment of change in coronary atherosclerotic plaque)

Presenter: Sanghoon Shin

October 25, 2023

Presentation TCT 2023

TCT 635: Performance of Near-Infrared Spectroscopy-Intravascular Ultrasound and Optical Coherence Tomography for Coronary Artery Plaque Structural Stress Analysis: Validation Against Histology

Presenter: Retesh Bajaj

October 25, 2023

Presentation TCT 2023

TCT 617: Plaque Stabilization and Regression: Another Significant Benefit of DynamX Bioadaptor

Presenter: Stefan Verheye

October 25, 2023

Presentation TCT 2023

TCT 177: Impact of Pericoronary Adipose Tissue Attenuation on Periprocedural Myocardial Injury in Patients with Chronic Coronary Syndrome

Presenter: Tetsuya Yamamoto

October 25, 2023

Presentation TCT 2023

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

Presenter: David del Val

October 25, 2023

Presentation TCT 2023

TCT 726: Efficacy of Renal Denervation and antihypertensives in patients with resistant hypertension: A systematic review and Network meta analysis

Presenter: Hamza Naveed

October 25, 2023

Presentation TCT 2023

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

Presenter: Michel Azizi

October 25, 2023

Presentation TCT 2023

TCT 210: Long-term Safety and Efficacy of Endovascular Ultrasound Renal Denervation in Resistant Hypertension: 8-year results from the ACHIEVE study

Presenter: Victor Zeijen

October 25, 2023

Presentation TCT 2023

TCT 207: Prediction of Six- and Twelve-Months Blood Pressure Results After Renal Denervation for Arterial Hypertension

Presenter: Karl Fengler

October 25, 2023

Presentation TCT 2023

TCT 152: Echocardiographic Findings Following Renal Sympathetic denervationfor treatment resistant hypertension, The ReShape CV-risk study.

Presenter: Anna Subbotina

October 25, 2023

Advertisement

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Hypertension Care Pathway with uRDN: Experiences from Clinical Trials

A High Standard of Clinical Evidence: Recent Key Milestones

TCT 628: The Impact of Long-term Exposure to Air Pollution on Plaque Characteristics Assessed by Intravascular Optical Coherence Tomography

TCT 555: NIRS-Detected Lipid-Rich Plaques are Highly Responsive to Novel Escalated LDL-C Reduction Therapy

TCT 379: Impact of the Residual Lipid Burden on the Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention

TCT 252: NIRS-IVUS assessment of OCT-derived Healed Coronary Plaques

TCT 235: Patterns of High-Risk Endothelial Shear Stress and Endothelial Shear Stress Gradients in Plaques with Abnormal vs Normal Resting Fractional Flow Reserve Ratio

TCT 161: Coronary Lipid Burden Early After Heart Transplantation as Assessed by Optical Coherence Tomography (OCT)

TCT 116: Clinical Outcomes of AMI Arising from Non-lipid-rich Plaque determined by NIRS-IVUS

TCT 645: Changes in Plaque Lipid Content After 1 year Intensive Versus Standard Statin Therapy : CITRUS study (Serial near-infrared spectroscopy assessment of change in coronary atherosclerotic plaque)

TCT 635: Performance of Near-Infrared Spectroscopy-Intravascular Ultrasound and Optical Coherence Tomography for Coronary Artery Plaque Structural Stress Analysis: Validation Against Histology

TCT 617: Plaque Stabilization and Regression: Another Significant Benefit of DynamX Bioadaptor

TCT 177: Impact of Pericoronary Adipose Tissue Attenuation on Periprocedural Myocardial Injury in Patients with Chronic Coronary Syndrome

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

TCT 726: Efficacy of Renal Denervation and antihypertensives in patients with resistant hypertension: A systematic review and Network meta analysis

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

TCT 210: Long-term Safety and Efficacy of Endovascular Ultrasound Renal Denervation in Resistant Hypertension: 8-year results from the ACHIEVE study

TCT 207: Prediction of Six- and Twelve-Months Blood Pressure Results After Renal Denervation for Arterial Hypertension

TCT 152: Echocardiographic Findings Following Renal Sympathetic denervationfor treatment resistant hypertension, The ReShape CV-risk study.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content